halothane has been researched along with glyburide in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bedoya, M; Decher, N; González, W; Kiper, AK; Ramírez, D; Rinné, S | 1 |
| Larach, DR; Schuler, HG | 1 |
| Fukushima, T; Hirasaki, A; Jones, KA; Warner, DO | 1 |
| Murray, PA; Nakayama, M; Sato, K; Seki, S | 1 |
| Horibe, M; Murray, PA; Seki, S | 1 |
| Coetzee, JF; Genade, S; le Roux, PJ; Lochner, A | 1 |
| Descorps-Declère, A; Frizelle, HP; Mazoit, JX; Sauviat, MP | 1 |
| Christensen, JD; Lynch, C; Roscoe, AK | 1 |
| Meadows, HJ; Randall, AD | 1 |
| de Klaver, MJ; Manning, L; Palmer, LA; Rich, GF | 1 |
| Kim, SJ; Kim, YH; Lee, J; Lee, JC; Shin, MH; Song, TB; Yoo, KY; Yoon, MH | 1 |
| Andria, B; Attanasio, C; Bucci, M; Calderone, V; Cantalupo, A; Cirino, G; Di Martino, A; Ianaro, A; Mancini, A; Panza, E; Savoia, G; Vellecco, V | 1 |
1 review(s) available for halothane and glyburide
| Article | Year |
|---|---|
TASK Channels Pharmacology: New Challenges in Drug Design.
Topics: Animals; Drug Design; Drug Discovery; Humans; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Tandem Pore Domain | 2019 |
14 other study(ies) available for halothane and glyburide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
Topics: Animals; Benzopyrans; Coronary Vessels; Cromakalim; Endothelium, Vascular; Glyburide; Halothane; In Vitro Techniques; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Pyrroles; Rats; Tetraethylammonium Compounds; Vasodilation | 1993 |
Halothane and potassium channels in airway smooth muscle.
Topics: Acetylcholine; Anesthetics, Inhalation; Animals; Benzoxazines; Cholinergic Agents; Cyclic N-Oxides; Dogs; Dose-Response Relationship, Drug; Glyburide; Halothane; Hypoglycemic Agents; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth; Oxazines; Potassium Channel Blockers; Potassium Channels; Tetraethylammonium; Tetraethylammonium Compounds; Trachea | 1996 |
Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzopyrans; Consciousness; Cromakalim; Dogs; Dose-Response Relationship, Drug; Enflurane; Glyburide; Halothane; Male; Potassium Channels; Pulmonary Circulation; Pyrroles; Vasodilation | 1997 |
Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzopyrans; Cromakalim; Dogs; Endothelium, Vascular; Glyburide; Halothane; Humans; Indomethacin; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Potassium Channels; Pulmonary Artery; Pyrroles; Vasodilation; Vasodilator Agents | 1997 |
Reduction of postischemic contractile dysfunction of the isolated rat heart by sevoflurane: comparison with halothane.
Topics: Adenine Nucleotides; Anesthetics, Inhalation; Animals; Glyburide; Halothane; Heart Arrest, Induced; Hemodynamics; In Vitro Techniques; Male; Methyl Ethers; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Rats; Rats, Wistar; Sevoflurane | 2000 |
Effects of halothane on the membrane potential in skeletal muscle of the frog.
Topics: Anesthetics, Inhalation; Animals; Charybdotoxin; Glyburide; Halothane; Hypoglycemic Agents; In Vitro Techniques; Membrane Potentials; Microelectrodes; Muscle, Skeletal; Potassium Channels; Rana esculenta; Ryanodine; Tetraethylammonium; Tetrodotoxin | 2000 |
Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Cell Hypoxia; Glyburide; Halothane; Heart; Humans; Hypoglycemic Agents; In Vitro Techniques; Ischemic Preconditioning; Isoflurane; Myocardial Contraction; Myocardium; Patch-Clamp Techniques; Potassium Channels; Receptors, Purinergic P1 | 2000 |
Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel.
Topics: 1-Methyl-3-isobutylxanthine; Acids; Animals; Barium Compounds; Bupivacaine; Cell Line; Cesium; Chlorides; Colforsin; Dose-Response Relationship, Drug; Female; Gene Expression; Glyburide; Halothane; Humans; Kinetics; Membrane Potentials; Oocytes; Potassium; Potassium Channels; Potassium Channels, Tandem Pore Domain; Pregnanediones; Tetradecanoylphorbol Acetate; Tetraethylammonium; Time Factors; Xenopus | 2001 |
Isoflurane pretreatment inhibits cytokine-induced cell death in cultured rat smooth muscle cells and human endothelial cells.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Cell Death; Cells, Cultured; Cytokines; Cytoprotection; DNA Fragmentation; Dose-Response Relationship, Drug; Endothelium, Vascular; Glyburide; Halothane; Humans; Hydrogen Peroxide; Isoflurane; Muscle, Smooth, Vascular; Potassium Channels; Protein Kinase C; Rats; Staurosporine | 2002 |
The effects of volatile anesthetics on spontaneous contractility of isolated human pregnant uterine muscle: a comparison among sevoflurane, desflurane, isoflurane, and halothane.
Topics: Anesthetics, Inhalation; Calcium; Desflurane; Dose-Response Relationship, Drug; Female; Glyburide; Halothane; Humans; In Vitro Techniques; Isoflurane; Methyl Ethers; Pregnancy; Sevoflurane; Tetraethylammonium Compounds; Uterine Contraction | 2006 |
Cystathionine β-synthase-derived hydrogen sulfide is involved in human malignant hyperthermia.
Topics: Biopsy; Caffeine; Case-Control Studies; Cystathionine beta-Synthase; Dose-Response Relationship, Drug; Gasotransmitters; Gene Expression Regulation, Enzymologic; Glyburide; Halothane; Humans; Hydrogen Sulfide; In Vitro Techniques; KATP Channels; Malignant Hyperthermia; Muscle Contraction; Muscle, Skeletal; Potassium Channel Blockers; RNA, Messenger; Signal Transduction; Sulfides; Up-Regulation | 2016 |